Desmond OathesInvestigator: Dr. Desmond Oathes

Disease: Depression and Posttraumatic stress disorder

Research Description: Repetitive transcranial magnetic stimulation (TMS) is a non-invasive FDA approved treatment for depression that does not respond well to medication. However, recent research suggests that using information from a patient’s brain images can help to improve TMS treatment outcomes. In addition, TMS has not yet been established for patients suffering from posttraumatic stress disorder (PTSD). We will use our combined expertise in brain imaging techniques and in TMS to treat two specific areas in the brains of patients who suffer from either depression, PTSD or both. Our expectation is that TMS treatment to our new brain target will improve symptoms in depression patients, compared to the current FDA approved treatment. We also expect that symptoms of PTSD will be improved with our targeted treatment. Therefore, the results from our study could form the basis of a new treatment for both PTSD and depression.

CWR funding role: Primary Funder

Start date: November 2016

Most recent report: Patient enrollment is expected to begin before the end of 2016

Anticipated next steps:

→ Data published in a scientific journal and/or presented at a scientific conference

→ Data leveraged into larger philanthropic or government funding for this treatment


Sign up for our eNewsletter today!


First Name

Cures Within Reach


Tuesday the 16th. copyright 2015 Cures Within Reach.